Figure 2.

Receiver operating characteristic analysis to define the best cutoffs of anti-peptide (Ap1-17, Ap17-30 and FOXE3p53-62) autoantibody levels discriminating anticentromere antibody-positive from and anticentromere antibody-negative patients (panels A to C), or from healthy blood donors (panels D to F). Ab, autoantibodies.

Perosa et al. Arthritis Research & Therapy 2013 15:R72   doi:10.1186/ar4249
Download authors' original image